Innovita Biological Technology Co., Ltd. (SHA:688253)
China · Delayed Price · Currency is CNY 57.41
-0.10 (-0.17%)
At close: Jun 2, 2026
SHA:688253 Market Cap
SHA:688253 has a market cap or net worth of 7.74 billion as of June 2, 2026. Its market cap has increased by 85.86% in one year.
Market Cap
7.74B
Enterprise Value
5.86B
Revenue
323.87M
Ranking
n/a
PE Ratio
87.01
Stock Price
57.41
Market Cap Chart
Since July 28, 2022, SHA:688253's market cap has increased from 4.49B to 7.74B, an increase of 72.45%. That is a compound annual growth rate of 15.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 7.76B | 90.56% |
| Dec 31, 2025 | 4.07B | -17.74% |
| Dec 31, 2024 | 4.95B | 45.41% |
| Dec 29, 2023 | 3.40B | 5.00% |
| Dec 30, 2022 | 3.24B | -27.82% |
| Jul 28, 2022 | 4.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangxi Fushine Pharmaceutical | 8.24B |
| Aurisco Pharmaceutical | 8.00B |
| Bio-Thera Solutions | 7.94B |
| GemPharmatech | 7.93B |
| Youcare Pharmaceutical Group | 7.92B |
| Zhejiang Ausun Pharmaceutical | 7.85B |
| Shanghai Medicilon | 7.85B |
| Beijing Hotgen Biotech | 7.79B |